ALK and cancer: A variety of ALK fusion genes resulting in constitutive activation of ALK, which is normally regulated by its extracellular ligand-binding domain in the full-length molecule, have been identified in human cancers (Grande et al., 2011; Hallberg and Palmer, 2013).